Logo image of REGI

Renewable Energy Group Inc (REGI) Stock Fundamental Analysis

NASDAQ:REGI - Nasdaq - US75972A3014 - Common Stock

61.5  +0.05 (+0.08%)

After market: 61.51 +0.01 (+0.02%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to REGI. REGI was compared to 208 industry peers in the Oil, Gas & Consumable Fuels industry. REGI may be in some trouble as it scores bad on both profitability and health. REGI is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year REGI was profitable.
REGI Yearly Net Income VS EBIT VS OCF VS FCFREGI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 0 200M 400M

1.2 Ratios

Industry RankSector Rank
ROA 8.61%
ROE 13.05%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
REGI Yearly ROA, ROE, ROICREGI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 0 20 -20

1.3 Margins

Industry RankSector Rank
OM 5.94%
PM (TTM) 5.41%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
REGI Yearly Profit, Operating, Gross MarginsREGI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 0 10 -10

3

2. Health

2.1 Basic Checks

REGI has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, REGI has a worse debt to assets ratio.
REGI Yearly Shares OutstandingREGI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 10M 20M 30M 40M 50M
REGI Yearly Total Debt VS Total AssetsREGI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 500M 1B 1.5B 2B 2.5B

2.2 Solvency

REGI has an Altman-Z score of 5.15. This indicates that REGI is financially healthy and has little risk of bankruptcy at the moment.
REGI has a Debt/Equity ratio of 0.31. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Altman-Z 5.15
ROIC/WACCN/A
WACCN/A
REGI Yearly LT Debt VS Equity VS FCFREGI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 0 500M 1B 1.5B

2.3 Liquidity

REGI has a Current Ratio of 5.14. This indicates that REGI is financially healthy and has no problem in meeting its short term obligations.
REGI has a Quick Ratio of 3.34. This indicates that REGI is financially healthy and has no problem in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 5.14
Quick Ratio 3.34
REGI Yearly Current Assets VS Current LiabilitesREGI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 500M 1B

9

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 98.40% over the past year.
REGI shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 29.44% yearly.
REGI shows a strong growth in Revenue. In the last year, the Revenue has grown by 89.66%.
REGI shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.73% yearly.
EPS 1Y (TTM)98.4%
EPS 3Y35.57%
EPS 5Y29.44%
EPS Q2Q%-71.59%
Revenue 1Y (TTM)89.66%
Revenue growth 3Y10.83%
Revenue growth 5Y9.73%
Sales Q2Q%73.43%

3.2 Future

The Earnings Per Share is expected to grow by 37.22% on average over the next years. This is a very strong growth
REGI is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 18.23% yearly.
EPS Next Y-17.72%
EPS Next 2Y-14.45%
EPS Next 3Y21.37%
EPS Next 5Y37.22%
Revenue Next Year4.54%
Revenue Next 2Y4.27%
Revenue Next 3Y15.74%
Revenue Next 5Y18.23%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
REGI Yearly Revenue VS EstimatesREGI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2B 4B 6B
REGI Yearly EPS VS EstimatesREGI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 5 10 15 20

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 16.49 indicates a correct valuation of REGI.
Compared to an average S&P500 Price/Earnings ratio of 26.54, REGI is valued a bit cheaper.
With a Price/Forward Earnings ratio of 19.27, REGI is valued on the expensive side.
The average S&P500 Price/Forward Earnings ratio is at 35.28. REGI is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 16.49
Fwd PE 19.27
REGI Price Earnings VS Forward Price EarningsREGI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 9.26
REGI Per share dataREGI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80

4.3 Compensation for Growth

A more expensive valuation may be justified as REGI's earnings are expected to grow with 21.37% in the coming years.
PEG (NY)N/A
PEG (5Y)0.56
EPS Next 2Y-14.45%
EPS Next 3Y21.37%

0

5. Dividend

5.1 Amount

No dividends for REGI!.
Industry RankSector Rank
Dividend Yield N/A

Renewable Energy Group Inc

NASDAQ:REGI (6/10/2022, 8:00:01 PM)

After market: 61.51 +0.01 (+0.02%)

61.5

+0.05 (+0.08%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)05-04 2022-05-04/amc
Earnings (Next)08-02 2022-08-02
Inst Owners0%
Inst Owner Change0%
Ins Owners13.83%
Ins Owner Change0%
Market Cap3.11B
Analysts71.76
Price Target69.08 (12.33%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 16.49
Fwd PE 19.27
P/S 0.74
P/FCF N/A
P/OCF N/A
P/B 1.79
P/tB N/A
EV/EBITDA 9.26
EPS(TTM)3.73
EY6.07%
EPS(NY)3.19
Fwd EY5.19%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS82.76
BVpS34.33
TBVpSN/A
PEG (NY)N/A
PEG (5Y)0.56
Profitability
Industry RankSector Rank
ROA 8.61%
ROE 13.05%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 5.94%
PM (TTM) 5.41%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover1.59
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.14
Quick Ratio 3.34
Altman-Z 5.15
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)98.4%
EPS 3Y35.57%
EPS 5Y29.44%
EPS Q2Q%-71.59%
EPS Next Y-17.72%
EPS Next 2Y-14.45%
EPS Next 3Y21.37%
EPS Next 5Y37.22%
Revenue 1Y (TTM)89.66%
Revenue growth 3Y10.83%
Revenue growth 5Y9.73%
Sales Q2Q%73.43%
Revenue Next Year4.54%
Revenue Next 2Y4.27%
Revenue Next 3Y15.74%
Revenue Next 5Y18.23%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A